(0)

ViroCyt

ViroCyt, LLC is the leader in the field of rapid virus quantification. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role.

Recent News

up
down
  • United States Department of Commerce Partners With ViroCyt to Expand Asian Markets

    BOULDER, CO–(Marketwired – Aug 27, 2014) - ViroCyt, LLC, the leader in rapid virus quantification, announced today that it is working with the US Department of Commerce’s Export Assistance Center In Denver to increase awareness of how the cutting edge Virus Counter system can be used to dramatically accelerate the creation of life-saving products. According to  Continue Reading »

    Read More arrow
  • United States Government-Supported Ebola Research Consortium Utilizes ViroCyt’s Technology for Rapid Virus Quantification

    BOULDER, CO–(Marketwire – August, 2014) - ViroCyt, LLC, the leader in rapid virus quantification, announced today that its breakthrough Virus Counter instrument is being used by a group of laboratories to develop filovirus medical countermeasures.  The Filovirus Animal Nonclinical Group or “FANG” is a US interdepartmental and interagency group established to support and facilitate the creation  Continue Reading »

    Read More arrow
  • ViroCyt Strengthens Management Team

    BOULDER, CO – (Marketwired – June 11, 2014) - ViroCyt, LLC, the leader in rapid virus quantification, announced today that Michael Olszowy, PhD, has joined the team as Chief Technology Officer. Dr. Olszowy is a formally trained cellular and molecular immunologist with 16 years of experience developing and commercializing life science technologies. Most recently, he held  Continue Reading »

    Read More arrow
  • New Rapid Virus Counter® System Introduced at World Vaccine Congress

    BOULDER, CO–(Marketwired – March 25, 2014) - ViroCyt, LLC, the leader in rapid virus quantification, announced today the introduction of the next generation Virus Counter at the World Vaccine Congress being held in Washington, DC.  The Virus Counter technology has already been adopted by the leading companies in the fields of viral vaccine development and therapeutic  Continue Reading »

    Read More arrow
  • ViroCyt Launches Rapid Virus Cleanup System: ViroPrep® Plus

    DENVER, CO–(Marketwired – Oct 1, 2013) - ViroCyt, LLC, the leader in rapid virus quantification, disclosed today availability of ViroPrep® Plus, a new product developed specifically for the purification of viruses from both egg- and cell-based systems. Quantification of viruses has been and continues to be a major chokepoint in a variety of different settings. These include: viral vaccine  Continue Reading »

    Read More arrow

Upcoming Events


Sep
19

Great Lakes International Imaging & Flow Cytometry Association Meeting Event Details

Oct
13

World Vaccine Congress Europe Event Details

Oct
27

ISBioTech 2nd Annual Fall Meeting Event Details

Apr
7

World Vaccine Congress US Event Details